Literature DB >> 4073666

The penetration of rifampicin, pyrazinamide, and pyrazinoic acid into mouse macrophages.

G Acocella, N A Carlone, A M Cuffini, G Cavallo.   

Abstract

The degree of penetration of rifampicin, pyrazinamide, and its metabolite pyrazinoic acid in mouse macrophages was evaluated over a period of 24 h. Cell cultures were exposed to 14C-labeled drugs at concentrations corresponding to peak, trough, and intermediate serum concentrations observed in humans after administration of therapeutic doses. The study was carried out with dead, resident, and stimulated peritoneal macrophages. The results indicated that the 3 compounds penetrate macrophages rapidly. At the lower concentrations, uptake of the 3 drugs is practically complete. With increasing concentrations, the absolute amount in the intracellular compartment increased. Comparison of the degree of penetration of the 3 drugs into dead, resident, and stimulated macrophages seems to suggest that the process of transfer through the macrophage wall is of a passive nature and not related to the metabolic state of the cells. Analysis of the binding of the 3 drugs to intracellular proteins indicated that more binding sites are probably available for rifampicin than for the other 2 drugs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4073666     DOI: 10.1164/arrd.1985.132.6.1268

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  11 in total

Review 1.  Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions.

Authors:  Sarah E Rowe; Jenna E Beam; Brian P Conlon
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

2.  Pyrazinamide is not effective against intracellularly growing Mycobacterium tuberculosis.

Authors:  N Rastogi; M C Potar; H L David
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

3.  Intrapulmonary concentrations of pyrazinamide.

Authors:  J E Conte; J A Golden; S Duncan; E McKenna; E Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

4.  Activity and penetration of antituberculosis drugs in mouse peritoneal macrophages infected with Mycobacterium microti OV254.

Authors:  J Dhillon; D A Mitchison
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

5.  Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin.

Authors:  John E Conte; Jeffrey A Golden; Juliana E Kipps; Emil T Lin; Elisabeth Zurlinden
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

6.  Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium.

Authors:  N Mor; J Vanderkolk; N Mezo; L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

7.  Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis.

Authors:  Ramesh Jayaram; Sheshagiri Gaonkar; Parvinder Kaur; B L Suresh; B N Mahesh; R Jayashree; Vrinda Nandi; Sowmya Bharat; R K Shandil; E Kantharaj; V Balasubramanian
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

8.  Reactive oxygen species induce antibiotic tolerance during systemic Staphylococcus aureus infection.

Authors:  Sarah E Rowe; Nikki J Wagner; Lupeng Li; Jenna E Beam; Alec D Wilkinson; Lauren C Radlinski; Qing Zhang; Edward A Miao; Brian P Conlon
Journal:  Nat Microbiol       Date:  2019-12-09       Impact factor: 17.745

9.  Entry of sanfetrinem into human polymorphonuclear granulocytes and its cell-associated activity against intracellular, penicillin-resistant Streptococcus pneumoniae.

Authors:  A M Cuffini; V Tullio; A Bonino; A Allocco; A I Palarchio; N A Carlone
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

10.  Primary Lung Dendritic Cell Cultures to Assess Efficacy of Spectinamide-1599 Against Intracellular Mycobacterium tuberculosis.

Authors:  Karen Santos; Pradeep B Lukka; Anne Grzegorzewicz; Mary Jackson; Ashit Trivedi; Fernando Pavan; Marlus Chorilli; Miriam Braunstein; Anthony Hickey; Bernd Meibohm; Mercedes Gonzalez-Juarrero
Journal:  Front Microbiol       Date:  2018-08-21       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.